Medical Student
David Geffen School of Medicine At UCLA, Department of Head and Neck Surgery
Los Angeles, CA, United States
Corinne Negvesky is a fourth-year medical student at the David Geffen School of Medicine, University of California, Los Angeles, currently completing a dedicated research year in otolaryngology. Her research focuses on the creation of novel topical therapeutics, specifically the sustained release of atorvastatin from a single application of microparticles within a thermosensitive hydrogel. This technology has the potential to mitigate cisplatin-induced ototoxicity, which leads to irreversible bilateral high-frequency sensorineural hearing loss and tinnitus in up to 60% and 40% of patients, respectively.
Beyond the wet lab, Corinne conducts research on resident education in rhinologic surgical instrumentation and non-opioid analgesia for office-based ENT procedures. She is interested in improving both training outcomes and patient care experiences.
Her passion for research began during her undergraduate training, where she received 1st place for the Community Service and Development Award at the American Medical Student Association's Annual Conference in Washington, D.C., for her research on providing telehealth interventions to seniors in disadvantaged communities. She earned her BS in Biochemistry with a minor in Business from Arizona State University.
Outside of her academic pursuits, Corinne volunteers as a court-appointed special advocate (CASA) for abused and neglected children. She also enjoys discovering new cultures through international travel and practices aerial art as a way to ground herself through movement.
Disclosure information not submitted.
Novel Atorvastatin-eluting Microparticles Provide Neuroprotection from Cisplatin Ototoxicity
Sunday, October 12, 2025
8:36 AM - 8:42 AM EDT